Principia Biopharma (Principia Biopharma) EV-to-EBITDA : -45.00 (As of May. 11, 2024)

Principia Biopharma EV-to-EBITDA Chart

Principia Biopharma Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
EV-to-EBITDA	Get a 7-Day Free Trial								79.03	-24.82	-20.11	-18.81	-22.59

Competitive Comparison of Principia Biopharma's EV-to-EBITDA

For the Biotechnology subindustry, Principia Biopharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Principia Biopharma's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Principia Biopharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Principia Biopharma's EV-to-EBITDA falls into.

Principia Biopharma EV-to-EBITDA Calculation

Principia Biopharma's EV-to-EBITDA for today is calculated as:

Principia Biopharma's current Enterprise Value is $3,023.44 Mil.
Principia Biopharma's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-67.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Principia Biopharma  (NAS:PRNB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Principia Biopharma's PE Ratio for today is calculated as:

Principia Biopharma's share price for today is $100.05.
Principia Biopharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.410.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Principia Biopharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Principia Biopharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Principia Biopharma (Principia Biopharma) Business Description